KIP Infrastructure
2.12.0 - ci-build
KIP Infrastructure, published by Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S. This guide is not an authorized publication; it is the continuous build for version 2.12.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/KIP-infrastructure/implementation-guide/ and changes regularly. See the Directory of published versions
| Active as of 2022-06-14 |
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="ATC"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CodeSystem ATC</b></p><a name="ATC"> </a><a name="hcATC"> </a><p>This case-sensitive code system <code>https://kip.rkkp.dk/fhir/CodeSystem/ATC</code> provides <b>a fragment</b> that includes following codes in an undefined hierarchy:</p><table class="codes"><tr><td><b>Lvl</b></td><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td>1</td><td style="white-space:nowrap">B01A<a name="ATC-B01A"> </a></td><td>ANTITHROMBOTIC AGENTS</td><td>B01A - ANTITHROMBOTIC AGENTS</td></tr><tr><td>2</td><td style="white-space:nowrap"> B01AA03<a name="ATC-B01AA03"> </a></td><td>warfarin</td><td>B01AA03 - warfarin</td></tr><tr><td>2</td><td style="white-space:nowrap"> B01AB01<a name="ATC-B01AB01"> </a></td><td>heparin</td><td>B01AB01 - heparin</td></tr><tr><td>2</td><td style="white-space:nowrap"> B01AB04<a name="ATC-B01AB04"> </a></td><td>dalteparin</td><td>B01AB04 - dalteparin</td></tr><tr><td>2</td><td style="white-space:nowrap"> B01AB05<a name="ATC-B01AB05"> </a></td><td>enoxaparin</td><td>B01AB05 - enoxaparin</td></tr><tr><td>2</td><td style="white-space:nowrap"> B01AB10<a name="ATC-B01AB10"> </a></td><td>tinzaparin</td><td>B01AB10 - tinzaparin</td></tr><tr><td>2</td><td style="white-space:nowrap"> B01AC06<a name="ATC-B01AC06"> </a></td><td>acetylsalicylic acid</td><td>B01AC06 - acetylsalicylic acid</td></tr><tr><td>2</td><td style="white-space:nowrap"> B01AE07<a name="ATC-B01AE07"> </a></td><td>dabigatran etexilate</td><td>B01AE07 - dabigatran etexilate</td></tr><tr><td>2</td><td style="white-space:nowrap"> B01AF01<a name="ATC-B01AF01"> </a></td><td>rivaroxaban</td><td>B01AF01 - rivaroxaban</td></tr><tr><td>2</td><td style="white-space:nowrap"> B01AF02<a name="ATC-B01AF02"> </a></td><td>apixaban</td><td>B01AF02 - apixaban</td></tr><tr><td>2</td><td style="white-space:nowrap"> B01AX05<a name="ATC-B01AX05"> </a></td><td>fondaparinux</td><td>B01AX05 - fondaparinux</td></tr><tr><td>1</td><td style="white-space:nowrap">B02AA02<a name="ATC-B02AA02"> </a></td><td>tranexamic acid</td><td>B02AA02 - Tranexamic acid</td></tr><tr><td>1</td><td style="white-space:nowrap">B03XA01<a name="ATC-B03XA01"> </a></td><td>erythropoietin</td><td>B03XA01 - erythropoietin</td></tr><tr><td>1</td><td style="white-space:nowrap">C10AA<a name="ATC-C10AA"> </a></td><td>HMG CoA reductase inhibitors</td><td>C10AA - HMG CoA reductase inhibitors</td></tr><tr><td>1</td><td style="white-space:nowrap">H02<a name="ATC-H02"> </a></td><td>CORTICOSTEROIDS FOR SYSTEMIC USE</td><td>H02 - CORTICOSTEROIDS FOR SYSTEMIC USE</td></tr><tr><td>1</td><td style="white-space:nowrap">J01CF01<a name="ATC-J01CF01"> </a></td><td>dicloxacillin</td><td>J01CF01 - dicloxacillin</td></tr><tr><td>1</td><td style="white-space:nowrap">J01CF02<a name="ATC-J01CF02"> </a></td><td>cloxacillin</td><td>J01CF02 - cloxacillin</td></tr><tr><td>1</td><td style="white-space:nowrap">J01CF03<a name="ATC-J01CF03"> </a></td><td>meticillin</td><td>J01CF03 - meticillin</td></tr><tr><td>1</td><td style="white-space:nowrap">J01CF05<a name="ATC-J01CF05"> </a></td><td>flucloxacillin</td><td>J01CF05 - flucloxacillin</td></tr><tr><td>1</td><td style="white-space:nowrap">J01DB01<a name="ATC-J01DB01"> </a></td><td>cefalexin</td><td>J01DB01 - cefalexin</td></tr><tr><td>1</td><td style="white-space:nowrap">J01DB03<a name="ATC-J01DB03"> </a></td><td>cefalotin</td><td>J01DB03 - cefalotin</td></tr><tr><td>1</td><td style="white-space:nowrap">J01DC02<a name="ATC-J01DC02"> </a></td><td>cefuroxime</td><td>J01DC02 - cefuroxime</td></tr><tr><td>1</td><td style="white-space:nowrap">J01FA01<a name="ATC-J01FA01"> </a></td><td>erythromycin</td><td>J01FA01 - erythromycin</td></tr><tr><td>1</td><td style="white-space:nowrap">J01GB03<a name="ATC-J01GB03"> </a></td><td>gentamicin</td><td>J01GB03 - gentamicin</td></tr><tr><td>1</td><td style="white-space:nowrap">J01XA01<a name="ATC-J01XA01"> </a></td><td>vancomycin</td><td>J01XA01 - vancomycin</td></tr><tr><td>1</td><td style="white-space:nowrap">L01AA01<a name="ATC-L01AA01"> </a></td><td>cyclophosphamide</td><td>L01AA01 - cyclophosphamide</td></tr><tr><td>1</td><td style="white-space:nowrap">L01AA02<a name="ATC-L01AA02"> </a></td><td>chlorambucil</td><td>L01AA02 - chlorambucil</td></tr><tr><td>1</td><td style="white-space:nowrap">L01AA03<a name="ATC-L01AA03"> </a></td><td>melphalan</td><td>L01AA03 - melphalan</td></tr><tr><td>1</td><td style="white-space:nowrap">L01AA06<a name="ATC-L01AA06"> </a></td><td>ifosfamide</td><td>L01AA06 - ifosfamide</td></tr><tr><td>1</td><td style="white-space:nowrap">L01AA09<a name="ATC-L01AA09"> </a></td><td>bendamustine</td><td>L01AA09 - bendamustine</td></tr><tr><td>1</td><td style="white-space:nowrap">L01AB01<a name="ATC-L01AB01"> </a></td><td>busulfan</td><td>L01AB01 - busulfan</td></tr><tr><td>1</td><td style="white-space:nowrap">L01AC01<a name="ATC-L01AC01"> </a></td><td>thiotepa</td><td>L01AC01 thiotepa</td></tr><tr><td>1</td><td style="white-space:nowrap">L01AD01<a name="ATC-L01AD01"> </a></td><td>carmustine</td><td>L01AD01 - carmustine</td></tr><tr><td>1</td><td style="white-space:nowrap">L01AX03<a name="ATC-L01AX03"> </a></td><td>temozolomide</td><td>L01AX03 - temozolomide</td></tr><tr><td>1</td><td style="white-space:nowrap">L01AX04<a name="ATC-L01AX04"> </a></td><td>dacarbazine</td><td>L01AX04 - dacarbazine</td></tr><tr><td>1</td><td style="white-space:nowrap">L01BB05<a name="ATC-L01BB05"> </a></td><td>fludarabine</td><td>L01BB05 - fludarabine</td></tr><tr><td>1</td><td style="white-space:nowrap">L01BC02<a name="ATC-L01BC02"> </a></td><td>fluorouracil</td><td>L01BC02 - Fluorouracil (5-FU)</td></tr><tr><td>1</td><td style="white-space:nowrap">L01BC05<a name="ATC-L01BC05"> </a></td><td>gemcitabine</td><td>L01BC02 - Gemcitabine</td></tr><tr><td>1</td><td style="white-space:nowrap">L01BC06<a name="ATC-L01BC06"> </a></td><td>capecitabine</td><td>L01BC06 - Capecitabine</td></tr><tr><td>1</td><td style="white-space:nowrap">L01BC07<a name="ATC-L01BC07"> </a></td><td>azacitidine</td><td>L01BC07 - azacitidine</td></tr><tr><td>1</td><td style="white-space:nowrap">L01CA02<a name="ATC-L01CA02"> </a></td><td>vincristine</td><td>L01CA02 - vincristine</td></tr><tr><td>1</td><td style="white-space:nowrap">L01CA04<a name="ATC-L01CA04"> </a></td><td>vinorelbine</td><td>L01CA04 - Vinorelbine</td></tr><tr><td>1</td><td style="white-space:nowrap">L01CB01<a name="ATC-L01CB01"> </a></td><td>etoposide</td><td>L01CB01 - etoposide</td></tr><tr><td>1</td><td style="white-space:nowrap">L01CD01<a name="ATC-L01CD01"> </a></td><td>paclitaxel</td><td>L01CD01 - Paclitaxel</td></tr><tr><td>1</td><td style="white-space:nowrap">L01CD02<a name="ATC-L01CD02"> </a></td><td>docetaxel</td><td>L01CD02 - Docetaxel</td></tr><tr><td>1</td><td style="white-space:nowrap">L01CE02<a name="ATC-L01CE02"> </a></td><td>irinotecan</td><td>L01CE02 - Irinotecan</td></tr><tr><td>1</td><td style="white-space:nowrap">L01DB01<a name="ATC-L01DB01"> </a></td><td>doxorubicin</td><td>L01DB01 - Doxorubicin</td></tr><tr><td>1</td><td style="white-space:nowrap">L01DB03<a name="ATC-L01DB03"> </a></td><td>epirubicin</td><td>L01DB03 - Epirubicin</td></tr><tr><td>1</td><td style="white-space:nowrap">L01DB07<a name="ATC-L01DB07"> </a></td><td>mitoxantrone</td><td>L01DB07 - mitoxantrone</td></tr><tr><td>1</td><td style="white-space:nowrap">L01DB11<a name="ATC-L01DB11"> </a></td><td>pixantrone</td><td>L01DB11 - pixantrone</td></tr><tr><td>1</td><td style="white-space:nowrap">L01DC01<a name="ATC-L01DC01"> </a></td><td>bleomycin</td><td>L01DC01 - bleomycin</td></tr><tr><td>1</td><td style="white-space:nowrap">L01EA<a name="ATC-L01EA"> </a></td><td>BCR-ABL tyrosine kinase inhibitors</td><td/></tr><tr><td>2</td><td style="white-space:nowrap"> L01EA01<a name="ATC-L01EA01"> </a></td><td>imatinib</td><td>L01EA01 - imatinib</td></tr><tr><td>2</td><td style="white-space:nowrap"> L01EA02<a name="ATC-L01EA02"> </a></td><td>dasatinib</td><td>L01EA02 - dasatinib</td></tr><tr><td>2</td><td style="white-space:nowrap"> L01EA03<a name="ATC-L01EA03"> </a></td><td>nilotinib</td><td>L01EA03 - nilotinib</td></tr><tr><td>2</td><td style="white-space:nowrap"> L01EA04<a name="ATC-L01EA04"> </a></td><td>bosutinib</td><td>L01EA04 - bosutinib</td></tr><tr><td>2</td><td style="white-space:nowrap"> L01EA05<a name="ATC-L01EA05"> </a></td><td>ponatinib</td><td>L01EA05 - ponatinib</td></tr><tr><td>2</td><td style="white-space:nowrap"> L01EA06<a name="ATC-L01EA06"> </a></td><td>Asciminib</td><td>L01EA06 - Asciminib</td></tr><tr><td>1</td><td style="white-space:nowrap">L01EB<a name="ATC-L01EB"> </a></td><td>Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors</td><td>L01EB - Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors</td></tr><tr><td>1</td><td style="white-space:nowrap">L01EH<a name="ATC-L01EH"> </a></td><td>Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors</td><td>L01EH - Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors</td></tr><tr><td>1</td><td style="white-space:nowrap">L01EJ<a name="ATC-L01EJ"> </a></td><td>Janus-associated kinase (JAK) inhibitors</td><td>Janus associerede kinase (JAK) hæmmere</td></tr><tr><td>2</td><td style="white-space:nowrap"> L01EJ01<a name="ATC-L01EJ01"> </a></td><td>ruxolitinib</td><td>L01EJ01 - ruxolitinib</td></tr><tr><td>1</td><td style="white-space:nowrap">L01EK<a name="ATC-L01EK"> </a></td><td>Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors</td><td>L01EK - Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors</td></tr><tr><td>1</td><td style="white-space:nowrap">L01EL01<a name="ATC-L01EL01"> </a></td><td>ibrutinib</td><td>L01EL01 - ibrutinib</td></tr><tr><td>1</td><td style="white-space:nowrap">L01EL02<a name="ATC-L01EL02"> </a></td><td>acalabrutinib</td><td>L01EL02 - acalabrutinib</td></tr><tr><td>1</td><td style="white-space:nowrap">L01EM01<a name="ATC-L01EM01"> </a></td><td>idelalisib</td><td>L01EM01 - idelalisib</td></tr><tr><td>1</td><td style="white-space:nowrap">L01EN<a name="ATC-L01EN"> </a></td><td>Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors</td><td>L01EN - Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors</td></tr><tr><td>1</td><td style="white-space:nowrap">L01FA01<a name="ATC-L01FA01"> </a></td><td>rituximab</td><td>L01FA01 - rituximab</td></tr><tr><td>1</td><td style="white-space:nowrap">L01FA02<a name="ATC-L01FA02"> </a></td><td>ofatumumab</td><td>L01FA02 - ofatumumab</td></tr><tr><td>1</td><td style="white-space:nowrap">L01FA03<a name="ATC-L01FA03"> </a></td><td>obinutuzumab</td><td>L01FA03 - obinutuzumab</td></tr><tr><td>1</td><td style="white-space:nowrap">L01FC01<a name="ATC-L01FC01"> </a></td><td>daratumumab</td><td>L01FC01 - daratumumab</td></tr><tr><td>1</td><td style="white-space:nowrap">L01FC02<a name="ATC-L01FC02"> </a></td><td>isatuximab</td><td>L01FC02 - isatuximab</td></tr><tr><td>1</td><td style="white-space:nowrap">L01FD01<a name="ATC-L01FD01"> </a></td><td>trastuzumab</td><td>L01FD01 - Trastuzumab</td></tr><tr><td>1</td><td style="white-space:nowrap">L01FF<a name="ATC-L01FF"> </a></td><td>PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors</td><td>L01FF - PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors</td></tr><tr><td>2</td><td style="white-space:nowrap"> L01FF01<a name="ATC-L01FF01"> </a></td><td>nivolumab</td><td>L01FF01 - Nivolumab</td></tr><tr><td>2</td><td style="white-space:nowrap"> L01FF02<a name="ATC-L01FF02"> </a></td><td>pembrolizumab</td><td>L01FF02 - Pembrolizumab</td></tr><tr><td>1</td><td style="white-space:nowrap">L01FG01<a name="ATC-L01FG01"> </a></td><td>bevacizumab</td><td>L01FG01 - Bevacizumab</td></tr><tr><td>1</td><td style="white-space:nowrap">L01FX05<a name="ATC-L01FX05"> </a></td><td>brentuximab vedotin</td><td>L01FX05 - brentuximab vedotin</td></tr><tr><td>1</td><td style="white-space:nowrap">L01FX08<a name="ATC-L01FX08"> </a></td><td>elotuzumab</td><td>L01FX08 - elotuzumab</td></tr><tr><td>1</td><td style="white-space:nowrap">L01FX14<a name="ATC-L01FX14"> </a></td><td>polatuzumab vedotin</td><td>L01FX14 - polatuzumab vedotin</td></tr><tr><td>1</td><td style="white-space:nowrap">L01XA01<a name="ATC-L01XA01"> </a></td><td>cisplatin</td><td>L01XA01 - Cisplatin</td></tr><tr><td>1</td><td style="white-space:nowrap">L01XA02<a name="ATC-L01XA02"> </a></td><td>carboplatin</td><td>L01XA02 - Carboplatin</td></tr><tr><td>1</td><td style="white-space:nowrap">L01XA03<a name="ATC-L01XA03"> </a></td><td>oxaliplatin</td><td>L01XA03 - Oxaliplatin</td></tr><tr><td>1</td><td style="white-space:nowrap">L01XG01<a name="ATC-L01XG01"> </a></td><td>bortezomib</td><td>L01XG01 - bortezomib</td></tr><tr><td>1</td><td style="white-space:nowrap">L01XG02<a name="ATC-L01XG02"> </a></td><td>carfilzomib</td><td>L01XG02 - carfilzomib</td></tr><tr><td>1</td><td style="white-space:nowrap">L01XG03<a name="ATC-L01XG03"> </a></td><td>ixazomib</td><td>L01XG03 - ixazomib</td></tr><tr><td>1</td><td style="white-space:nowrap">L01XH<a name="ATC-L01XH"> </a></td><td>Histone deacetylase (HDAC) inhibitors</td><td>L01XH - Histone deacetylase (HDAC) inhibitors</td></tr><tr><td>2</td><td style="white-space:nowrap"> L01XH01<a name="ATC-L01XH01"> </a></td><td>vorinostat</td><td>L01XH01 - vorinostat</td></tr><tr><td>2</td><td style="white-space:nowrap"> L01XH03<a name="ATC-L01XH03"> </a></td><td>panobinostat</td><td>L01XH03 - panobinostat</td></tr><tr><td>1</td><td style="white-space:nowrap">L01XX05<a name="ATC-L01XX05"> </a></td><td>hydroxycarbamide</td><td>L01XX05 - hydroxycarbamide</td></tr><tr><td>1</td><td style="white-space:nowrap">L01XX35<a name="ATC-L01XX35"> </a></td><td>anagrelide</td><td>L01XX35 - anagrelide</td></tr><tr><td>1</td><td style="white-space:nowrap">L01XX52<a name="ATC-L01XX52"> </a></td><td>venetoclax</td><td>L01XX52 - venetoclax</td></tr><tr><td>1</td><td style="white-space:nowrap">L03AB<a name="ATC-L03AB"> </a></td><td>Interferons</td><td>L03AB - Interferons</td></tr><tr><td>1</td><td style="white-space:nowrap">L04A<a name="ATC-L04A"> </a></td><td>IMMUNOSUPPRESSANTS</td><td>L04A - IMMUNOSUPPRESSANTS</td></tr><tr><td>2</td><td style="white-space:nowrap"> L04AA<a name="ATC-L04AA"> </a></td><td>Selective immunosuppressants</td><td>L04AA - Selective immunosuppressants</td></tr><tr><td>3</td><td style="white-space:nowrap"> L04AA34<a name="ATC-L04AA34"> </a></td><td>alemtuzumab</td><td>L04AA34 - alemtuzumab</td></tr><tr><td>3</td><td style="white-space:nowrap"> L04AA40<a name="ATC-L04AA40"> </a></td><td>cladribine</td><td>L04AA40 - cladribine</td></tr><tr><td>1</td><td style="white-space:nowrap">L04AD01<a name="ATC-L04AD01"> </a></td><td>ciclosporin</td><td>L04AD01 - ciclosporin</td></tr><tr><td>1</td><td style="white-space:nowrap">L04AX02<a name="ATC-L04AX02"> </a></td><td>thalidomide</td><td>L04AX02 - thalidomide</td></tr><tr><td>1</td><td style="white-space:nowrap">L04AX04<a name="ATC-L04AX04"> </a></td><td>lenalidomide</td><td>L04AX04 - lenalidomide</td></tr><tr><td>1</td><td style="white-space:nowrap">L04AX06<a name="ATC-L04AX06"> </a></td><td>pomalidomide</td><td>L04AX06 - pomalidomide</td></tr><tr><td>1</td><td style="white-space:nowrap">M05BA03<a name="ATC-M05BA03"> </a></td><td>pamidronic acid</td><td>M05BA03 - pamidronic acid</td></tr><tr><td>1</td><td style="white-space:nowrap">M05BA08<a name="ATC-M05BA08"> </a></td><td>zoledronic acid</td><td>M05BA08 - zoledronic acid</td></tr><tr><td>1</td><td style="white-space:nowrap">M05BX04<a name="ATC-M05BX04"> </a></td><td>denosumab</td><td>M05BX04 - denosumab</td></tr><tr><td>1</td><td style="white-space:nowrap">S01LA08<a name="ATC-S01LA08"> </a></td><td>bevacizumab</td><td>S01LA08 - Bevacizumab</td></tr><tr><td>1</td><td style="white-space:nowrap">V10X<a name="ATC-V10X"> </a></td><td>OTHER THERAPEUTIC RADIOPHARMACEUTICALS</td><td>V10X - OTHER THERAPEUTIC RADIOPHARMACEUTICALS</td></tr><tr><td>2</td><td style="white-space:nowrap"> V10XA53<a name="ATC-V10XA53"> </a></td><td>tositumomab/iodine (131I) tositumomab</td><td>V10XA53 - tositumomab/iodine (131I) tositumomab</td></tr><tr><td>2</td><td style="white-space:nowrap"> V10XX02<a name="ATC-V10XX02"> </a></td><td>ibritumomab tiuxetan (90Y)</td><td>V10XX02 - ibritumomab tiuxetan (90Y)</td></tr></table></div>
</text>
<url value="https://kip.rkkp.dk/fhir/CodeSystem/ATC"/>
<identifier>
<value value="urn:oid:2.16.840.1.113883.6.73"/>
</identifier>
<version value="2.12.0"/>
<name value="ATC"/>
<title value="WHO ATC"/>
<status value="active"/>
<date value="2022-06-14T00:00:00+02:00"/>
<publisher
value="Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S"/>
<contact>
<name
value="Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S"/>
<telecom>
<system value="url"/>
<value value="https://trifork.com"/>
</telecom>
<telecom>
<system value="email"/>
<value value="rbk@trifork.com"/>
</telecom>
</contact>
<description value="WHO ATC code system. Link: http://www.whocc.no/atc"/>
<caseSensitive value="true"/>
<content value="fragment"/>
<concept>
<code value="B01A"/>
<display value="ANTITHROMBOTIC AGENTS"/>
<definition value="B01A - ANTITHROMBOTIC AGENTS"/>
<concept>
<code value="B01AA03"/>
<display value="warfarin"/>
<definition value="B01AA03 - warfarin"/>
</concept>
<concept>
<code value="B01AB01"/>
<display value="heparin"/>
<definition value="B01AB01 - heparin"/>
</concept>
<concept>
<code value="B01AB04"/>
<display value="dalteparin"/>
<definition value="B01AB04 - dalteparin"/>
</concept>
<concept>
<code value="B01AB05"/>
<display value="enoxaparin"/>
<definition value="B01AB05 - enoxaparin"/>
</concept>
<concept>
<code value="B01AB10"/>
<display value="tinzaparin"/>
<definition value="B01AB10 - tinzaparin"/>
</concept>
<concept>
<code value="B01AC06"/>
<display value="acetylsalicylic acid"/>
<definition value="B01AC06 - acetylsalicylic acid"/>
</concept>
<concept>
<code value="B01AE07"/>
<display value="dabigatran etexilate"/>
<definition value="B01AE07 - dabigatran etexilate"/>
</concept>
<concept>
<code value="B01AF01"/>
<display value="rivaroxaban"/>
<definition value="B01AF01 - rivaroxaban"/>
</concept>
<concept>
<code value="B01AF02"/>
<display value="apixaban"/>
<definition value="B01AF02 - apixaban"/>
</concept>
<concept>
<code value="B01AX05"/>
<display value="fondaparinux"/>
<definition value="B01AX05 - fondaparinux"/>
</concept>
</concept>
<concept>
<code value="B02AA02"/>
<display value="tranexamic acid"/>
<definition value="B02AA02 - Tranexamic acid"/>
</concept>
<concept>
<code value="B03XA01"/>
<display value="erythropoietin"/>
<definition value="B03XA01 - erythropoietin"/>
</concept>
<concept>
<code value="C10AA"/>
<display value="HMG CoA reductase inhibitors"/>
<definition value="C10AA - HMG CoA reductase inhibitors"/>
</concept>
<concept>
<code value="H02"/>
<display value="CORTICOSTEROIDS FOR SYSTEMIC USE"/>
<definition value="H02 - CORTICOSTEROIDS FOR SYSTEMIC USE"/>
</concept>
<concept>
<code value="J01CF01"/>
<display value="dicloxacillin"/>
<definition value="J01CF01 - dicloxacillin"/>
</concept>
<concept>
<code value="J01CF02"/>
<display value="cloxacillin"/>
<definition value="J01CF02 - cloxacillin"/>
</concept>
<concept>
<code value="J01CF03"/>
<display value="meticillin"/>
<definition value="J01CF03 - meticillin"/>
</concept>
<concept>
<code value="J01CF05"/>
<display value="flucloxacillin"/>
<definition value="J01CF05 - flucloxacillin"/>
</concept>
<concept>
<code value="J01DB01"/>
<display value="cefalexin"/>
<definition value="J01DB01 - cefalexin"/>
</concept>
<concept>
<code value="J01DB03"/>
<display value="cefalotin"/>
<definition value="J01DB03 - cefalotin"/>
</concept>
<concept>
<code value="J01DC02"/>
<display value="cefuroxime"/>
<definition value="J01DC02 - cefuroxime"/>
</concept>
<concept>
<code value="J01FA01"/>
<display value="erythromycin"/>
<definition value="J01FA01 - erythromycin"/>
</concept>
<concept>
<code value="J01GB03"/>
<display value="gentamicin"/>
<definition value="J01GB03 - gentamicin"/>
</concept>
<concept>
<code value="J01XA01"/>
<display value="vancomycin"/>
<definition value="J01XA01 - vancomycin"/>
</concept>
<concept>
<code value="L01AA01"/>
<display value="cyclophosphamide"/>
<definition value="L01AA01 - cyclophosphamide"/>
</concept>
<concept>
<code value="L01AA02"/>
<display value="chlorambucil"/>
<definition value="L01AA02 - chlorambucil"/>
</concept>
<concept>
<code value="L01AA03"/>
<display value="melphalan"/>
<definition value="L01AA03 - melphalan"/>
</concept>
<concept>
<code value="L01AA06"/>
<display value="ifosfamide"/>
<definition value="L01AA06 - ifosfamide"/>
</concept>
<concept>
<code value="L01AA09"/>
<display value="bendamustine"/>
<definition value="L01AA09 - bendamustine"/>
</concept>
<concept>
<code value="L01AB01"/>
<display value="busulfan"/>
<definition value="L01AB01 - busulfan"/>
</concept>
<concept>
<code value="L01AC01"/>
<display value="thiotepa"/>
<definition value="L01AC01 thiotepa"/>
</concept>
<concept>
<code value="L01AD01"/>
<display value="carmustine"/>
<definition value="L01AD01 - carmustine"/>
</concept>
<concept>
<code value="L01AX03"/>
<display value="temozolomide"/>
<definition value="L01AX03 - temozolomide"/>
</concept>
<concept>
<code value="L01AX04"/>
<display value="dacarbazine"/>
<definition value="L01AX04 - dacarbazine"/>
</concept>
<concept>
<code value="L01BB05"/>
<display value="fludarabine"/>
<definition value="L01BB05 - fludarabine"/>
</concept>
<concept>
<code value="L01BC02"/>
<display value="fluorouracil"/>
<definition value="L01BC02 - Fluorouracil (5-FU)"/>
</concept>
<concept>
<code value="L01BC05"/>
<display value="gemcitabine"/>
<definition value="L01BC02 - Gemcitabine"/>
</concept>
<concept>
<code value="L01BC06"/>
<display value="capecitabine"/>
<definition value="L01BC06 - Capecitabine"/>
</concept>
<concept>
<code value="L01BC07"/>
<display value="azacitidine"/>
<definition value="L01BC07 - azacitidine"/>
</concept>
<concept>
<code value="L01CA02"/>
<display value="vincristine"/>
<definition value="L01CA02 - vincristine"/>
</concept>
<concept>
<code value="L01CA04"/>
<display value="vinorelbine"/>
<definition value="L01CA04 - Vinorelbine"/>
</concept>
<concept>
<code value="L01CB01"/>
<display value="etoposide"/>
<definition value="L01CB01 - etoposide"/>
</concept>
<concept>
<code value="L01CD01"/>
<display value="paclitaxel"/>
<definition value="L01CD01 - Paclitaxel"/>
</concept>
<concept>
<code value="L01CD02"/>
<display value="docetaxel"/>
<definition value="L01CD02 - Docetaxel"/>
</concept>
<concept>
<code value="L01CE02"/>
<display value="irinotecan"/>
<definition value="L01CE02 - Irinotecan"/>
</concept>
<concept>
<code value="L01DB01"/>
<display value="doxorubicin"/>
<definition value="L01DB01 - Doxorubicin"/>
</concept>
<concept>
<code value="L01DB03"/>
<display value="epirubicin"/>
<definition value="L01DB03 - Epirubicin"/>
</concept>
<concept>
<code value="L01DB07"/>
<display value="mitoxantrone"/>
<definition value="L01DB07 - mitoxantrone"/>
</concept>
<concept>
<code value="L01DB11"/>
<display value="pixantrone"/>
<definition value="L01DB11 - pixantrone"/>
</concept>
<concept>
<code value="L01DC01"/>
<display value="bleomycin"/>
<definition value="L01DC01 - bleomycin"/>
</concept>
<concept>
<code value="L01EA"/>
<display value="BCR-ABL tyrosine kinase inhibitors"/>
<concept>
<code value="L01EA01"/>
<display value="imatinib"/>
<definition value="L01EA01 - imatinib"/>
</concept>
<concept>
<code value="L01EA02"/>
<display value="dasatinib"/>
<definition value="L01EA02 - dasatinib"/>
</concept>
<concept>
<code value="L01EA03"/>
<display value="nilotinib"/>
<definition value="L01EA03 - nilotinib"/>
</concept>
<concept>
<code value="L01EA04"/>
<display value="bosutinib"/>
<definition value="L01EA04 - bosutinib"/>
</concept>
<concept>
<code value="L01EA05"/>
<display value="ponatinib"/>
<definition value="L01EA05 - ponatinib"/>
</concept>
<concept>
<code value="L01EA06"/>
<display value="Asciminib"/>
<definition value="L01EA06 - Asciminib"/>
</concept>
</concept>
<concept>
<code value="L01EB"/>
<display
value="Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors"/>
<definition
value="L01EB - Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors"/>
</concept>
<concept>
<code value="L01EH"/>
<display
value="Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors"/>
<definition
value="L01EH - Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors"/>
</concept>
<concept>
<code value="L01EJ"/>
<display value="Janus-associated kinase (JAK) inhibitors"/>
<definition value="Janus associerede kinase (JAK) hæmmere"/>
<concept>
<code value="L01EJ01"/>
<display value="ruxolitinib"/>
<definition value="L01EJ01 - ruxolitinib"/>
</concept>
</concept>
<concept>
<code value="L01EK"/>
<display
value="Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors"/>
<definition
value="L01EK - Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors"/>
</concept>
<concept>
<code value="L01EL01"/>
<display value="ibrutinib"/>
<definition value="L01EL01 - ibrutinib"/>
</concept>
<concept>
<code value="L01EL02"/>
<display value="acalabrutinib"/>
<definition value="L01EL02 - acalabrutinib"/>
</concept>
<concept>
<code value="L01EM01"/>
<display value="idelalisib"/>
<definition value="L01EM01 - idelalisib"/>
</concept>
<concept>
<code value="L01EN"/>
<display
value="Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors"/>
<definition
value="L01EN - Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors"/>
</concept>
<concept>
<code value="L01FA01"/>
<display value="rituximab"/>
<definition value="L01FA01 - rituximab"/>
</concept>
<concept>
<code value="L01FA02"/>
<display value="ofatumumab"/>
<definition value="L01FA02 - ofatumumab"/>
</concept>
<concept>
<code value="L01FA03"/>
<display value="obinutuzumab"/>
<definition value="L01FA03 - obinutuzumab"/>
</concept>
<concept>
<code value="L01FC01"/>
<display value="daratumumab"/>
<definition value="L01FC01 - daratumumab"/>
</concept>
<concept>
<code value="L01FC02"/>
<display value="isatuximab"/>
<definition value="L01FC02 - isatuximab"/>
</concept>
<concept>
<code value="L01FD01"/>
<display value="trastuzumab"/>
<definition value="L01FD01 - Trastuzumab"/>
</concept>
<concept>
<code value="L01FF"/>
<display
value="PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors"/>
<definition
value="L01FF - PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors"/>
<concept>
<code value="L01FF01"/>
<display value="nivolumab"/>
<definition value="L01FF01 - Nivolumab"/>
</concept>
<concept>
<code value="L01FF02"/>
<display value="pembrolizumab"/>
<definition value="L01FF02 - Pembrolizumab"/>
</concept>
</concept>
<concept>
<code value="L01FG01"/>
<display value="bevacizumab"/>
<definition value="L01FG01 - Bevacizumab"/>
</concept>
<concept>
<code value="L01FX05"/>
<display value="brentuximab vedotin"/>
<definition value="L01FX05 - brentuximab vedotin"/>
</concept>
<concept>
<code value="L01FX08"/>
<display value="elotuzumab"/>
<definition value="L01FX08 - elotuzumab"/>
</concept>
<concept>
<code value="L01FX14"/>
<display value="polatuzumab vedotin"/>
<definition value="L01FX14 - polatuzumab vedotin"/>
</concept>
<concept>
<code value="L01XA01"/>
<display value="cisplatin"/>
<definition value="L01XA01 - Cisplatin"/>
</concept>
<concept>
<code value="L01XA02"/>
<display value="carboplatin"/>
<definition value="L01XA02 - Carboplatin"/>
</concept>
<concept>
<code value="L01XA03"/>
<display value="oxaliplatin"/>
<definition value="L01XA03 - Oxaliplatin"/>
</concept>
<concept>
<code value="L01XG01"/>
<display value="bortezomib"/>
<definition value="L01XG01 - bortezomib"/>
</concept>
<concept>
<code value="L01XG02"/>
<display value="carfilzomib"/>
<definition value="L01XG02 - carfilzomib"/>
</concept>
<concept>
<code value="L01XG03"/>
<display value="ixazomib"/>
<definition value="L01XG03 - ixazomib"/>
</concept>
<concept>
<code value="L01XH"/>
<display value="Histone deacetylase (HDAC) inhibitors"/>
<definition value="L01XH - Histone deacetylase (HDAC) inhibitors"/>
<concept>
<code value="L01XH01"/>
<display value="vorinostat"/>
<definition value="L01XH01 - vorinostat"/>
</concept>
<concept>
<code value="L01XH03"/>
<display value="panobinostat"/>
<definition value="L01XH03 - panobinostat"/>
</concept>
</concept>
<concept>
<code value="L01XX05"/>
<display value="hydroxycarbamide"/>
<definition value="L01XX05 - hydroxycarbamide"/>
</concept>
<concept>
<code value="L01XX35"/>
<display value="anagrelide"/>
<definition value="L01XX35 - anagrelide"/>
</concept>
<concept>
<code value="L01XX52"/>
<display value="venetoclax"/>
<definition value="L01XX52 - venetoclax"/>
</concept>
<concept>
<code value="L03AB"/>
<display value="Interferons"/>
<definition value="L03AB - Interferons"/>
</concept>
<concept>
<code value="L04A"/>
<display value="IMMUNOSUPPRESSANTS"/>
<definition value="L04A - IMMUNOSUPPRESSANTS"/>
<concept>
<code value="L04AA"/>
<display value="Selective immunosuppressants"/>
<definition value="L04AA - Selective immunosuppressants"/>
<concept>
<code value="L04AA34"/>
<display value="alemtuzumab"/>
<definition value="L04AA34 - alemtuzumab"/>
</concept>
<concept>
<code value="L04AA40"/>
<display value="cladribine"/>
<definition value="L04AA40 - cladribine"/>
</concept>
</concept>
</concept>
<concept>
<code value="L04AD01"/>
<display value="ciclosporin"/>
<definition value="L04AD01 - ciclosporin"/>
</concept>
<concept>
<code value="L04AX02"/>
<display value="thalidomide"/>
<definition value="L04AX02 - thalidomide"/>
</concept>
<concept>
<code value="L04AX04"/>
<display value="lenalidomide"/>
<definition value="L04AX04 - lenalidomide"/>
</concept>
<concept>
<code value="L04AX06"/>
<display value="pomalidomide"/>
<definition value="L04AX06 - pomalidomide"/>
</concept>
<concept>
<code value="M05BA03"/>
<display value="pamidronic acid"/>
<definition value="M05BA03 - pamidronic acid"/>
</concept>
<concept>
<code value="M05BA08"/>
<display value="zoledronic acid"/>
<definition value="M05BA08 - zoledronic acid"/>
</concept>
<concept>
<code value="M05BX04"/>
<display value="denosumab"/>
<definition value="M05BX04 - denosumab"/>
</concept>
<concept>
<code value="S01LA08"/>
<display value="bevacizumab"/>
<definition value="S01LA08 - Bevacizumab"/>
</concept>
<concept>
<code value="V10X"/>
<display value="OTHER THERAPEUTIC RADIOPHARMACEUTICALS"/>
<definition value="V10X - OTHER THERAPEUTIC RADIOPHARMACEUTICALS"/>
<concept>
<code value="V10XA53"/>
<display value="tositumomab/iodine (131I) tositumomab"/>
<definition value="V10XA53 - tositumomab/iodine (131I) tositumomab"/>
</concept>
<concept>
<code value="V10XX02"/>
<display value="ibritumomab tiuxetan (90Y)"/>
<definition value="V10XX02 - ibritumomab tiuxetan (90Y)"/>
</concept>
</concept>
</CodeSystem>